Apotex Defends Declaration In Acular Patent Suit

Law360, New York (August 28, 2007, 12:00 AM EDT) -- Apotex Inc. has asserted that a key declaration by a doctor bolsters its opposition to Allergan Inc.’s bid for summary judgment, which alleges the Canadian generic drug maker infringed a patent for Acular when Apotex submitted an application for a generic copy of the itchy eye treatment.

Apotex insisted Tuesday that the U.S. District Court for the Northern District of California should consider the doctor’s declaration as part of its arguments against Allergan’s motion because it raises doubts over whether Apotex’s generic formulation could infringe the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.